|
⚲
|
| Keyboard |
| Davis Todd C
✚
|
|
|---|---|
| CIK # | 0001392029 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001392029] | |
| 4 | [0001392029] | |
| 5 | [0001392029] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Davis Todd C | |
| Ligand Pharmaceuticals Inc | |
| Channel Therapeutics Corp | |
| Palvella Therapeutics Inc | |
| NABI Biopharmaceuticals | |
| Biodelivery Sciences International Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-03-02 | Grant | 10,495 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2026-03-02 | Grant | 50,058 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-02-15 | Tax withheld | 2,805 | $183.83 | 515,643 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-02-15 | Tax withheld | 4,255 | $183.83 | 782,197 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-02-15 | Tax withheld | 2,039 | $183.83 | 374,829 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-02-14 | Grant | 20,782 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-02-14 | Grant | 39,644 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-02-14 | Tax withheld | 8,178 | $183.83 | 1,503,362 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2026-02-14 | Tax withheld | 15,600 | $183.83 | 2,867,748 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-12-04 | Gift | 130 | $0.00 | |
|
Channel Therapeutics Corp PTHS
Restricted Stock Units · derivative
|
2025-07-02 | Grant | 19,108 | ||
|
Channel Therapeutics Corp PTHS
Stock Option · derivative
|
2025-07-02 | Grant | 58,230 | ||
|
Channel Therapeutics Corp PTHS
Series A Convertible Preferred Stock · derivative
|
2025-07-01 | Other | 31,278.68 | ||
|
Channel Therapeutics Corp PTHS
Common Stock
|
2025-07-01 | Conversion | 1,500,000 | $10.00 | 15,000,000 |
|
Channel Therapeutics Corp PTHS
Series A Convertible Preferred Stock · derivative
|
2025-07-01 | Conversion | 15,000 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-06-30 | Other | 233 | $91.08 | 21,222 |
|
Palvella Therapeutics Inc PVLA
Non-Qualified Stock Option (right to buy) · derivative
|
2025-06-10 | Grant | 12,350 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-05-09 | Buy | 5,523 | $105.67 | 583,615 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-05-09 | Buy | 2,307 | $104.53 | 241,151 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2025-05-09 | Buy | 1,680 | $104.57 | 175,678 |
| showing 20 of 141 most recent transactions | |||||